ROR1 exhibits high and homogeneous cell surface expression in many epithelial tumors with expression profile similar to PTK7, and targeting ROR1 with CAR T-cell therapy improved survival in xenograft models of ROR1+ human tumors with treating lung and breast cancer in an ongoing clinical trial (NCT02706392) (38, 40). Here, ROR1 is linked to breast carcinoma.